Subscribe to PRO at just Rs.33 per month. Use code SUPERPRO
you are here: HomeNewsIndia
Last Updated : Sep 14, 2020 03:56 PM IST | Source: Moneycontrol.com

India managed to limit COVID-19 deaths to 55 per 10 lakh population: Harsh Vardhan

India's COVID-19 case fatality rate also remains around 1.6 percent, significantly lower than some of the major country with a similarly high caseload.

Representative image
Representative image

Union Health Minister Dr Harsh Vardhan informed the Lok Sabha on September 14 that India had managed to limit its COVID-19 cases and fatalities to 3,328 infections and 55 deaths per 10 lakh population, respectively.

"With our endeavour to manage COVID-19, India has been able to limit its cases and deaths to 3,328 cases and 55 deaths per million population, respectively, which is one of the lowest in the world as compared to similarly affected countries," the minister said, according to reports.

The health minister claimed that the decision to impose a nationwide lockdown had prevented additional 14-29 lakh COVID-19 cases and 37,000-78,000 deaths in the country.


Despite registering well over 11 lakh COVID-19 cases in the first two weeks of September, India’s recovery rate has touched 78 percent.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

According to data from the Union Health Ministry, more than 77,500 patients recovered from COVID-19, the disease caused by the novel coronavirus, in the previous 24-hour period. With that, the total recoveries in the country surged to over 37.8 lakh.

As of September 14, India had recorded 48.4 lakh confirmed COVID-19 cases, including 79,722 fatalities. About 9.8 lakh cases remain ‘active’, the data suggests.


Follow our LIVE blog for the latest updates of the novel coronavirus pandemic

India’s overall tally is the second-highest in the world, after United States.

In a statement, the Health Ministry noted that 60 percent of the active cases are in five most-affected states: Maharashtra, Karnataka, Andhra Pradesh, Uttar Pradesh and Tamil Nadu. These states, however, have also reported 60 percent of the total recoveries so far.

The case fatality rate also remains around 1.6 percent, significantly lower than some of the other major country with a similarly high caseload.

Click here for Moneycontrol’s full coverage of the novel coronavirus pandemic
First Published on Sep 14, 2020 03:56 pm